Clinical Trials Using Porcupine Inhibitor WNT974
Clinical trials are research studies that involve people. The clinical trials on this list are studying Porcupine Inhibitor WNT974. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
This primary purpose of this study is to find the recommended dose of LGK974 as a single agent and in combination with PDR001 that can be safely given to adult patients with selected solid malignancies for whom no effective standard treatment is available.
Location: 7 locations